IJMS | Free Full-Text | New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination
New targeted therapies for non-small-cell lung cancer
The Future will be Di�erent than Today: Model Evaluation Considerations when Developing Translational Clinical Biomarker
Massimo CICCOZZI | Associate Professor Head of medical statistic and molecular epidemiology Unit | epidemiologist and biostatistician | Faculty of medicine | Research profile
Europass CV
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available | Journal of Clinical Pathology
Federico Cappuzzo - AI Profile | 人才画像- AMiner
Oncologia Medica 2 - Istituti Fisioterapici Ospitalieri - IFO
Dr. Federico Cappuzzo Oncologo
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC)
Dr. Federico Cappuzzo Oncologo – Nueva Group
Cappuzzo Federico - Medici eccellenti cancro polmone | alcase.eu
Untitled
Gli Esperti IFO rispondono | cancro del polmone | alcase.eu
Il dottor Federico Cappuzzo riceve l'abilitazione a professore ordinario in oncologia
NOTE
Congress Report
Federico Cappuzzo – TROVA MEDICO
Untitled
PDF) Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives
Federico Cappuzzo | Lung Cancer Specialist
Congress Report
CV Cappuzzo 2017_Europass IT
Federico Cappuzzo - Direttore - IFO - Istituto Nazionale Tumori Regina Elena - Istituto Dermatologico San Gallicano | LinkedIn
Cancers | Free Full-Text | Serum Metabolite Profiles in Participants of Lung Cancer Screening Study; Comparison of Two Independent Cohorts
Clinical Research Technology - Posts | Facebook
